Mirel 18 Mg Kit 1

• Mirel Kit is used in the management of acute ST-elevation myocardial infarction (STEMI) to reduce the risk of death and heart failure.

• Active internal bleeding.
• History of stroke.
• Recent intracranial or intraspinal surgery or serious head trauma (within 3 months).
• Intracranial conditions that increase the risk of bleeding (for example, brain tumor, arteriovenous malformation, or aneurysm).
• Known bleeding diathesis (bleeding disorder).
• Current severe uncontrolled high blood pressure.

• Bleeding at the injection or puncture site
• Reactions at the injection site, such as burning sensations.
• Bleeding in the gastrointestinal tract
• Bleeding in the urinary tract (genitourinary)
• Anemia (low red blood cell count) from blood loss of unknown site

Other General Warnings

• You have had a recent stroke, brain or spine surgery, or serious head trauma within the last 3 months.
• You have a brain tumor, abnormal brain blood vessels (arteriovenous malformation), or an aneurysm.
• You have a bleeding disorder or active internal bleeding.
• You have severe high blood pressure that is not controlled.
• You are older, particularly over 70 years of age, or have high blood pressure, as the risk of bleeding in the brain is higher.
• You have had a previous allergic reaction to a clot-dissolving medicine.
• You have had, or are planning, an invasive vascular procedure (such as cardiac catheterization or angiography) or take blood thinners, as the risk of cholesterol embolism is higher.

• Mirel Kit is given by a doctor or nurse in a hospital or emergency care setting as soon as possible after the onset of STEMI symptoms.
• Do not inject or infuse other medicines through the same intravenous line or add them to the injection solution.
• Patients should never attempt to change, delay, skip, or repeat a dose on their own.

• Mirel Kit is a hospital-administered medicine, so the pharmacy or emergency team normally handles storage, preparation, and disposal.
• Store at 2°C to 25°C (36°F to 77°F), and keep the box sealed until use to protect the powder from light. It should not be frozen.

• Inform your doctor if you notice bleeding, new bruising, or blood in your urine or stools.
• Seek urgent medical attention if you develop any rash, itching, swelling of the tongue, or difficulty breathing.
• Intramuscular (into the muscle) injections and other trauma should be avoided after Mirel Kit is given. Blood draws for testing and needle punctures are kept to a minimum during treatment.
• Tell your doctor if you Inform your doctor if you have high blood pressure that is not controlled, have had a stroke, brain or spine surgery, a head injury, or a bleeding disorder.
• Inform your doctor if you have received Mirel Kit before any blood test, as clotting test results may be unreliable.

Overdose

Missed a Dose

Interactions with other medicines

• Mirel Kit is incompatible with heparin. Do not give it through an intravenous line containing heparin.
• Coagulation tests and measures of clot-dissolving activity are unreliable during treatment unless special precautions prevent laboratory sample errors. Inform laboratory and care staff that you have received Mirel Kit.
• Patients should tell their doctor about all prescription medicines, over-the-counter medicines, supplements, and herbal products they are taking, especially blood thinners.